The Evolution of <i>TP53</i> Mutations: From Loss-of-Function to Separation-of-Function Mutants.

Abstract

As the most mutated gene in cancer, it is no surprise that <i>TP53</i> has been the center of cancer biology discourse since its discovery in the late 1970s. Although early demonstrations of p53's role in the modulation of cell proliferation and survival solidified its classification as a tumor suppressor and transcription factor, our conceptualization of p53 is ever-evolving. Here, we present novel evidence of the role of alternative splicing isoforms, truncating/separation-of-function mutations, and hotspot silent mutations in the regulation of p53's activities.